Cereno Scientific AB Statistics

Total Valuation

Cereno Scientific AB has a market cap or net worth of SEK 1.44 billion. The enterprise value is 1.45 billion.

Market Cap	1.44B
Enterprise Value	1.45B

Important Dates

The next estimated earnings date is Tuesday, February 25, 2025.

Earnings Date	Feb 25, 2025
Ex-Dividend Date	n/a

Share Statistics

Cereno Scientific AB has 281.70 million shares outstanding. The number of shares has increased by 54.61% in one year.

Current Share Class	n/a
Shares Outstanding	281.70M
Shares Change (YoY)	+54.61%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	14.13%
Owned by Institutions (%)	25.32%
Float	241.30M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	17.98
PB Ratio	6.23
P/TBV Ratio	6.62
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-17.91
EV / Sales	16.75
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-20.33

Financial Position

The company has a current ratio of 3.25, with a Debt / Equity ratio of 0.39.

Current Ratio	3.25
Quick Ratio	3.17
Debt / Equity	0.39
Debt / EBITDA	n/a
Debt / FCF	-1.26
Interest Coverage	-4.17

Financial Efficiency

Return on equity (ROE) is -34.73% and return on invested capital (ROIC) is -14.92%.

Return on Equity (ROE)	-34.73%
Return on Assets (ROA)	-14.02%
Return on Capital (ROIC)	-14.92%
Revenue Per Employee	17.35M
Profits Per Employee	-16.22M
Employee Count	5
Asset Turnover	0.29
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +18.06% in the last 52 weeks. The beta is 0.35, so Cereno Scientific AB's price volatility has been lower than the market average.

Beta (5Y)	0.35
52-Week Price Change	+18.06%
50-Day Moving Average	5.37
200-Day Moving Average	5.24
Relative Strength Index (RSI)	38.62
Average Volume (20 Days)	770,463

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cereno Scientific AB had revenue of SEK 86.75 million and -81.12 million in losses. Loss per share was -0.27.

Revenue	86.75M
Gross Profit	86.75M
Operating Income	-66.59M
Pretax Income	-81.12M
Net Income	-81.12M
EBITDA	-66.49M
EBIT	-66.59M
Loss Per Share	-0.27

Full Income Statement

Balance Sheet

The company has 73.84 million in cash and 90.40 million in debt, giving a net cash position of -16.56 million or -0.06 per share.

Cash & Cash Equivalents	73.84M
Total Debt	90.40M
Net Cash	-16.56M
Net Cash Per Share	-0.06
Equity (Book Value)	230.73M
Book Value Per Share	0.82
Working Capital	54.33M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -70.20 million and capital expenditures -1.27 million, giving a free cash flow of -71.47 million.

Operating Cash Flow	-70.20M
Capital Expenditures	-1.27M
Free Cash Flow	-71.47M
FCF Per Share	-0.25

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -76.76% and -93.51%.

Gross Margin	100.00%
Operating Margin	-76.76%
Pretax Margin	-93.51%
Profit Margin	-93.51%
EBITDA Margin	-76.65%
EBIT Margin	-76.76%
FCF Margin	n/a

Dividends & Yields

Cereno Scientific AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-54.61%
Shareholder Yield	-54.61%
Earnings Yield	-5.20%
FCF Yield	-4.97%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cereno Scientific AB has an Altman Z-Score of 6.06.

Altman Z-Score	6.06
Piotroski F-Score	n/a